ADMA Biologics Inc vs Prudential Financial Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Prudential Financial Inc trades at $122.19 (market cap $42.20B). The key difference: Prudential Financial Inc is far larger — about 19× ADMA Biologics Inc's market cap, and Prudential Financial Inc pays a 4.58% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | PRU | |
|---|---|---|
Market Cap | $2.22B | $42.20B |
Sector | Health | Financials |
52-Week High | $20.38 | $123.93 |
52-Week Low | $7.60 | $92.00 |
Enterprise Value | $2.29B | $70.98B |
Dividend Yield | — | 4.58% |
Trailing returns across standard periods
Latest headlines on both assets
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →Prudential Financial is a large, diversified insurance company offering annuities, life insurance, retirement plan services, and asset management products. While it operates in a number of countries, the vast majority of revenue is generated in the United States and Japan. The company's investment management business, PGIM, contributes approximately 15% of its earnings and has over $1.5 trillion in assets under management. The U.S. businesses are responsible for about 45% of earnings and can be classified into Institutional Retirement Strategies, Individual Retirement Strategies, Group Insurance, Individual Life Insurance, and Assurance IQ. Finally, the international business segment of the company contributes approximately 40% of earnings with a strong market position in Japan.
Read more on PRU →